Actively Recruiting
Comparing Pregabalin Alone Versus Pregabalin Combined With Venlafaxine for Treating Fibromyalgia in a Multicenter Randomized Trial
Led by Beijing Tiantan Hospital · Updated on 2026-09-02
750
Participants Needed
2
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying fibromyalgia FM, a chronic pain condition marked by widespread pain, fatigue, and emotional challenges. The trial aims to compare the effects and safety of pregabalin alone versus pregabalin combined with venlafaxine, hypothesizing that the combination may provide better pain relief without more side effects. The study is a randomized, multicenter clinical trial focused on treatment outcomes for adults with FM. Participants will be assigned to one of two groups one receiving pregabalin alone and the other receiving pregabalin with venlafaxine. Pregabalin treatment starts at 150 mgday and may increase to 450 mgday based on response. Venlafaxine begins at 75 mgday with possible weekly increases up to 225 mgday if tolerated. Treatment doses are adjusted individually over the study period. During the 12-week trial, participants will regularly report their pain levels, including average and worst pain intensity, at weeks 1, 2, 4, 8, and 12. Researchers will also assess functional impact, sleep quality, mood, medication doses, and any adverse events. These ongoing evaluations help monitor treatment effects and safety throughout the study duration.
CONDITIONS
Brief Title
The Efficacy and Safety of Pregabalin Combined With Venlafaxine in Patients With Fibromyalgia
Research Team
F
Fang Luo
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here